Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02752724 · ClinicalTrials.gov registry record · NA
Ketamine Anesthesia for Improvement of Depression in ECT
A NA study, sponsored by VA Puget Sound Health Care System.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT02752724 is a NA study that has completed, run by VA Puget Sound Health Care System. The registered enrollment target is 52 participants.
The verdict
NCT02752724, a NA study, has completed, sponsored by VA Puget Sound Health Care System.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
The purpose of this prospective randomized clinical trial is to determine if patients receiving ketamine as a part of general anesthesia during electroconvulsive therapy (ECT) rather than standard of care will have improvement in symptoms of depression after a course of ECT treatments. The investigators hypothesize that utilization of ketamine for induction of general anesthesia during ECT treatments will improve symptoms of depression better than standard care. This study is ONLY open to patients eligible to receive healthcare services through the Department of Veterans Affairs at the VA Puget Sound, which means service in the active military, naval or air service or separation under any condition other than dishonorable. Qualifications for VA health care benefits can be found at va.gov.
Interventions
- DRUG Ketamine
- DRUG Methohexital
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2016-03 |
| Est. Completion | 2018-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02752724
The ClinicalTrials.gov registry entry for NCT02752724 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Puget Sound Health Care System, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketamine is the first listed.
NCT02752724 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02752724 about?
NCT02752724 is a clinical study titled "Ketamine Anesthesia for Improvement of Depression in ECT". The purpose of this prospective randomized clinical trial is to determine if patients receiving ketamine as a part of general anesthesia during electroconvulsive therapy (ECT) rather than standard of care will have improvement in symptoms of depression after a course of ECT treatments. The investiga...
What is the current status of trial NCT02752724?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2016-03. Estimated completion is 2018-04-30.
What interventions are being tested in trial NCT02752724?
The interventions under investigation include: Ketamine (DRUG), Methohexital (DRUG).
Who is sponsoring clinical trial NCT02752724?
This trial is sponsored by VA Puget Sound Health Care System, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.